ISDA

Deposition Date 2008-08-19

Release Date 2008-10-14

Last Version Date 2024-11-13

Entry Detail

PDB ID:

3E88

Keywords:

TRANSFERASE

Title:

Crystal structures of the kinase domain of AKT2 in complex with ATP-competitive inhibitors

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)
(Taxon ID: )

Host Organism:

Spodoptera frugiperda

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.50 Å

R-Value Free:

0.27

R-Value Work:

0.22

R-Value Observed:

0.23

Space Group:

P 32

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:RAC-beta serine/threonine-protein kinase
Gene (Uniprot):AKT2
Mutations:S474D
Chain IDs:A, B
Chain Length:335
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:P31751 Pfam ID:PF00069, PF00433 EC:2.7.11.1

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Glycogen synthase kinase-3 beta peptide
Gene (Uniprot):GSK3B
Chain IDs:C, D
Chain Length:10
Number of Molecules:2
Biological Source:

UniProt ID:P49841 EC:2.7.11.26

Modified Residue

Compound ID	Chain ID	Parent Comp ID	Details	2D Image
TPO	A	THR	PHOSPHOTHREONINE

Ligand Molecules

G96

Primary Citation

Aminofurazans as potent inhibitors of AKT kinase

Rouse, M.B, Seefeld, M.A, Leber, J.D, McNulty, K.C, Sun, L, Miller, W.H, Zhang, S, Minthorn, E.A, Concha, N.O, Choudhry, A.E, Schaber, M.D, Heerding, D.A, Seefeld, M.A, Rouse, M.B, McNulty, K.C, Sun, L, Wang, J, Yamashita, D.S, Choudhry, A, Schaber, M.D, Kumar, R, Kahana, J, Zhang, S.Y, Minthorn, E.A, Koretke, K.K, Concha, N.O, Heerding, D.A.Show

Bioorg.Med.Chem.Lett. 19 1508 1511 (2009)

PMID: 19179070 DOI: 10.1016/j.bmcl.2009.01.002

Abstact

AKT inhibitors containing an imidazopyridine aminofurazan scaffold have been optimized. We have previously disclosed identification of the AKT inhibitor GSK690693, which has been evaluated in clinical trials in cancer patients. Herein we describe recent efforts focusing on investigating a distinct region of this scaffold that have afforded compounds (30 and 32) with comparable activity profiles to that of GSK690693.

Legend

Protein

Chemical

Disease

Primary Citation of related structures